Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: Differentiation of passive and nonexposure and correlation with neonatal outcome measures

Clinical Chemistry

Volumn 54, Issue 12, 2008, Pages 2018-2027

  Gray, Teresa R ^a   Magri, Raquel ^b   Shakleya, Diaa M ^a   Huestis, Marilyn A ^a,c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Centro Hospitalario Pereira Rossell   (Uruguay)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; BIOLOGICAL MARKER; COTININE; GLUCURONIDE; NICOTINE; NICOTINE DERIVATIVE; NORCOTININE; NORNICOTINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANALYTIC METHOD; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MECONIUM; METABOLITE; NEWBORN; OUTCOME ASSESSMENT; PRENATAL EXPOSURE; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TOBACCO;

APGAR SCORE; BIOLOGICAL MARKERS; BODY SIZE; CHROMATOGRAPHY, LIQUID; COTININE; FEMALE; GESTATIONAL AGE; GLUCURONATES; HUMANS; HYDROLYSIS; INFANT, NEWBORN; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MECONIUM; NICOTINE; PREGNANCY; SMOKING; TANDEM MASS SPECTROMETRY; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 57149110073     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.109173     Document Type: Article

References (31)

1. U.S. Department of Health and Human Services. Reproductive effects. In: The health consequences of smoking: a report of the Surgeon General. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004. p 550-601.
2. Haddow JE, Knight GJ, Palomaki GE, Kloza EM, Wald NJ. Cigarette consumption and serum cotinine in relation to birthweight. Br J Obstet Gynaecol 1987;94:678-81.
3. Li CQ, Windsor RA, Perkins L, Goldenberg RL, Lowe JB. The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 1993;269:1519-24.
4. Ellard GA, Johnstone FD, Prescott RJ, Ji-Xian W, Jian-Hua M. Smoking during pregnancy: the dose dependence of birthweight deficits. Br J Obstet Gynaecol 1996;103:806-13.
5. Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, Hobbs CA. Maternal smoking and congenital heart defects. Pediatrics 2008;121:e810-6.
6. Jeppesen DL, Nielsen SD, Ersbøll AK, Valerius NH. Maternal Smoking during pregnancy increases the risk of postnatal infections in preterm neonates. Neonatology 2008;94:75-8.
7. Jaddoe VWV, Troe E-JWM, Hofman A, Mackenbach JP, Moll HA, Steegers EAP, Witteman JCM. Active and passive maternal smoking during pregnancy and the risks of low birthweight and preterm birth: the Generation R Study. Paediatr Perinat Epidemiol 2008;22:162-71.
8. Ward C, Lewis S, Coleman T. Prevalence of maternal smoking and environmental tobacco smoke exposure during pregnancy and impact on birth weight: retrospective study using Millennium Cohort. BMC Public Health 2007;7:81.
9. Nakamura MU, Alexandre SM, Kuhn dos Santos JF, de Souza E, Sass N, Auritscher Beck AP, et al. Obstetric and perinatal effects of active and/or passive smoking during pregnancy. São Paulo Med J 2004;122:94-8.
10. Steyn K, de Wet T, Saloojee Y, Nel H, Yach D. The influence of maternal cigarette smoking, snuff use and passive smoking on pregnancy outcomes: the Birth To Ten Study. Paediatr Perinat Epidemiol 2006;20:90-9.
11. Klebanoff MA, Levine RJ, Clemens JD, DerSimonian R, Wilkins DG. Serum cotinine concentration and self-reported smoking during pregnancy. Am J Epidemiol 1998;148:259-62.
12. Boyd NR, Windsor RA, Perkins LL, Lowe JB. Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Matern Child Health J 1998;2:77-83.
13. Lindqvist R, Lendahls L, Tollbom O, Aberg H, Hakansson A. Smoking during pregnancy: comparison of self-reports and cotinine levels in 496 women. Acta Obstet Gynecol Scand 2002;81:240-4.
14. George L, Granath F, Johansson AL, Cnattingius S. Self-reported nicotine exposure and plasma levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand 2006;85:1331-7.
15. Walsh RA, Redman S, Adamson L. The accuracy of self-report of smoking status in pregnant women. Addict Behav 1996;21:675-9.
16. England LJ, Grauman A, Qian C, Wilkins DG, Schisterman EF, Yu KF, Levine RJ. Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine Tobacco Res 2007;9:1005-13.
17. Baranowski J, Pochopien G, Baranowska I. Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998;707:317-21.
18. Dempsey D, Moore C, Deitermann D, Lewis D, Feeley B, Niedbala RS. The detection of cotinine in hydrolyzed meconium samples. Forensic Sci Int 1999;102:167-71.
19. Ostrea EM, Knapp DK, Romero AI, Montes M, Ostrea AR. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. J Pediatr 1994;124:471-6.
20. Sherif NA, Kamel SM, Al-Ashkar OS, Sharaki OA, Seif EA, Hegazy EA. Detection of cotinine in neonate meconium as a marker for nicotine exposure in utero. East Mediterr Health J 2004;10:96-105.
21. Pereg D, Lagueux J, Dewailly E, Poirier GG, Ayotte P. Cigarette smoking during pregnancy: comparison of biomarkers for inclusion in epidemiological studies. Biomarkers 2001;6:161-73.
22. Nuesslein TG, Beckers D, Rieger CH. Cotinine in meconium indicates risk for early respiratory tract infections. Hum Exp Toxicol 1999;18:283-90.
23. Schepers G, Walk RA. Cotinine determination by immunoassays may be influenced by other nicotine metabolites. Arch Toxicol 1988;62:395-7.
24. Zuccaro P, Pichini S, Altieri I, Rosa M, Pellegrini M, Pacifici R. Interference of nicotine metabolites in cotinine determination by RIA. Clin Chem 1997;43:180-1.
25. Gray TR, Shakleya DM, Huestis MA. Quantification of nicotine, cotinine, trans-3′-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography tandem mass spectrometry. J Chrom B 2008;863:107-14.
26. Kohler E, Avenarius S, Rabsilber A, Gerloff C, Jorch G. Assessment of prenatal tobacco smoke exposure by determining nicotine and its metabolites in meconium. Hum Exp Toxicol 2007;26:535-44.
27. Kuehl GE, Murphy SE. N-glucuronidation of trans-3′- hydroxycotinine by human liver microsomes. Chem Res Toxicol 2003;16:1502-6.
28. Yamanaka H, Nakajima M, Katoh M, Kanoh A, Tamura O, Ishibashi H, Yokoi T. Trans-3′-hydroxycotinine O- and N-glucuronidations in human liver microsomes. Drug Metab Dispos 2005;33:23-30.
29. Shafey O, Dolwick S, Guindon GE, eds. Tobacco control country profiles 2003. 2nd ed. Atlanta (GA): American Cancer Society; 2003. p 420-1.
30. Pastrakuljic A, Schwartz R, Simone C, Derewlany LO, Knie B, Koren G. Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci 1998;63:2333-42.
31. Sastry BV, Chance MB, Hemontolor ME, Goddijn-Wessel TA. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology 1998;57:104-16.